在较年轻年龄诊断单基因卒中
该研究对50例≤55岁首次卒中先证者进行全基因组测序,使用卒中基因面板评估低频变异,15例(30%)检出临床匹配的遗传变异,但仅6例(12%)建立较强临床关联;心源性栓塞亚型检出率最高(4/5,80%)。
要点
- ≤55岁首次卒中患者中,全基因组测序结合卒中基因面板可检出单基因病因。
- 15/50(30%)检出临床匹配遗传变异,仅6/50(12%)建立较强临床关联。
- 心源性栓塞亚型检出率4/5(80%),颈动脉夹层卒中仅1/11(9%)。
核心结论
- 使用卒中基因面板对全基因组数据进行仔细临床解读可检出早发卒中的单基因病因,从而实现个体化随访并为潜在治疗提供新可能。
研究设计与样本
- 研究纳入50例首次卒中年龄≤55岁的先证者,进行临床特征分析和全基因组测序。
- 先证者需满足以下至少一条:一至二级亲属60岁前卒中或相同致卒中疾病;无高血压、高胆固醇血症、糖尿病、心脏病或吸烟;多次卒中发作或多次动脉夹层。
- 使用卒中基因面板评估次要等位基因频率低于0.01的变异。
主要发现
- 50例患者中15例(30%)检出17个临床匹配的遗传变异,仅6例(12%)建立与卒中的较强临床关联。
- 心源性栓塞亚型患者中4/5(80%)检出卒中相关遗传变异。
- 脑出血患者中3/4(75%)检出卒中相关遗传变异。
- 隐源性栓塞性卒中患者中7/18(39%)检出卒中相关遗传变异。
- 小血管病患者中1/6(17%)检出卒中相关遗传变异;非动脉粥样硬化性大动脉卒中患者中3/15(20%)检出,其中颈动脉夹层卒中1/11(9%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An increasing number of monogenic conditions underlying stroke are being identified. We explored the possibilities of increasing the diagnostic yield of monogenic stroke in a population under 56 years of age. METHODS: Fifty probands ≤55 years at their first stroke episode were characterized clinically and investigated by whole genome sequencing. Probands had one or more of: (1) one or more first to second degree relatives with stroke under 60 years or same stroke-causing condition/disease; (2) no hypertension, hypercholesterolemia, diabetes, heart disease, or smoking; or (3) either multiple stroke episodes or multiple arterial dissections. Variants with minor allele frequency under 0.01, identified by using our stroke gene panels, were assessed. The stroke subtypes, including large artery atherosclerotic, large artery nonatherosclerotic (tortuosity, dolichoectasia, aneurysm, nonatherosclerotic dissection, or occlusion), cerebral small vessel disease, cardioembolic (arrhythmia, heart defect, or cardiomyopathy), coagulation dysfunctions (venous thrombosis, arterial thrombosis, or bleeding tendency), intracerebral hemorrhage, vascular malformations (cavernoma or arteriovenous malformations), metabolic disorders, or cryptogenic embolic, were used for genotype-phenotype correlation. In a final step, we combined genetic and clinical information to determine if the genetic variant likely was the cause of stroke in the patients. RESULTS: Whole genome sequencing of younger patients with stroke identified 17 clinically matching genetic variants in 15 of 50 (30%) patients, while a stronger clinical correlation with stroke was established in only 6 (12%) of them. Stroke-related genetic variants were identified in 4 of 5 (80%) patients with cardioembolic stroke subtype, 3 of 4 (75%) with intracerebral hemorrhage, 7 of 18 (39%) with cryptogenic embolic stroke, 1 of 6 (17%) with small vessel disease, and 3 of 15 (20%) of patients with nonatherosclerotic large artery stroke, including 1 of 11 (9%) with cervical dissection stroke. CONCLUSIONS: Careful clinical interpretation of whole genome data using stroke gene panels can detect monogenic causes of early stroke, allowing individualized follow-up and opening new possibilities for potential treatment.
引用
- Ilinca A, Kafantari E, Wallenius J, et al. Diagnosing Monogenic Stroke at Younger Age. Stroke. 2024. PMID: 39498567. doi:10.1161/STROKEAHA.124.048044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。